Hypoglycemia requiring ambulance services in patients with type 2 diabetes is associated with increased long-term mortality

Endocrine Practice

Volumn 19, Issue 1, 2013, Pages 29-35

  Parsaik, Ajay K ^a   Carter, Rickey E ^a   Myers, Lucas A ^a   Basu, Ananda ^a   Kudva, Yogish C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ANTIDIABETIC AGENT;

ADULT; AGED; ALCOHOL INTOXICATION; AMBULANCE; ARTICLE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC KETOACIDOSIS; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG INTOXICATION; FAINTNESS; FEMALE; HEART ARREST; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; INJURY; INSULIN TREATMENT; KETONURIA; KIDNEY FAILURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS TRANSPLANTATION; PERIPHERAL VASCULAR DISEASE; TRANSIENT ISCHEMIC ATTACK; EMERGENCY HEALTH SERVICE; MIDDLE AGED; MORTALITY; RISK; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMBULANCES; DIABETES MELLITUS, TYPE 2; EMERGENCY MEDICAL SERVICES; FEMALE; HOSPITALIZATION; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; RISK;

EID: 84881540183     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP12197.OR     Document Type: Article

References (24)

1. Cryer PE. Elimination of hypoglycemia from the lives of people affected by diabetes. Diabetes. 2011;60:24-27.
2. Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial. Ann Intern Med. 1996;124:379-388.
3. Ben-Ami H, Nagachandran P, Mendelson A, Edoute Y. Drug-induced hypoglycemic coma in 102 diabetic patients. Arch Intern Med. 1999;159:281-284. (Pubitemid 29075648)
4. Laing SP, Swerdlow AJ, Slater SD. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med. 1999;16:466-471.
5. Abraira C, Colwell JA, Nuttall FQ, et al. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care. 1995;18:1113-1123.
6. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
7. Hepburn DA, MacLeod KM, Pell AC, Scougal IJ, Frier BM. Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin. Diabet Med. 1993;10:231-237. (Pubitemid 23096131)
8. Evans JM, Ogston SA, Emslie-Smith A, Morris AD. Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: A comparison of patients treated with sulfonylureas and metformin. Diabetologia. 2006;49:930-936.
9. Daniels A, White M, Stander I, Crone D. Ambulance visits for severe hypoglycaemia in insulin-treated diabetes. N Z Med J. 1999;112:225-228. (Pubitemid 29299803)
10. Zoungas S, Patel A, Chalmers J. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010;363:1410-1418.
11. Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545-2559. (Pubitemid 351831356)
12. Parsaik AK, Carter RE, Pattan V, et al. Population-based study of severe hypoglycemia requiring emergency medical service assistance reveals unique findings. J Diabetes Sci Technol. 2012;6:65-73.
13. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-865.
14. Gulliford M, Latinovic R. Mortality in type 2 diabetic subjects prescribed metformin and sulphonylurea drugs in combination: cohort study. Diabetes Metab Res Rev. 2004;20:239-245. (Pubitemid 38714323)
15. Johnson JA, Majumdar SR, Simpson SH, Toth EL. Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes. Diabetes Care. 2002;25:2244-2448.
16. Ginde AA, Espinola JA, Camargo CA Jr. Trends and disparities in U.S. emergency department visits for hypoglycemia, 1993-2005. Diabetes Care. 2008;31:511-513.
17. United States Census Bureau. Olmsted County, Minnesota. Last updated August 16, 2012. http://quickfacts.census.gov/qfd/states/27/27109.html. Accessed for verification August 17, 2012.
18. Leese GP, Wang J, Broomhall J, et al. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care. 2003;26:1176-1180. (Pubitemid 36929268)
19. Arlt W. The approach to the adult with newly diagnosed adrenal insufficiency. J Clin Endocrinol Metab. 2009;94:1059-1067.
20. Collier JD, Ninkovic M, Compston JE. Guidelines on the management of osteoporosis associated with chronic liver disease. Gut. 2002;50(Suppl 1):i1-9. (Pubitemid 41185465)
21. National Kidney Foundation. Calculators for Health Care Professionals. http://www.kidney.org/professionals/kdoqi/gfr-calculator.cfm. Accessed for verification August 17, 2012.
22. MN Health Atlas.: Mapping Diabetes in Minnesota. Data Visualization - Customization. http://www.mnhealthatlas.org/data-visualization/customization/ 602011. 2012. Accessed for verification August 17, 2012.
23. Fisman EZ, Tenenbaum A, Boyko V, et al. Oral antidiabetic treatment in patients with coronary disease: time-related increased mortality on combined glyburide/metformin therapy over a 7.7-year follow-up. Clin Cardiol. 2001;24:151-158. (Pubitemid 32108625)
24. Olsson J, Lindberg G, Gottsäter M, et al. Increased mortality in Type II diabetic patients using sulphonylurea and metformin in combination: A population-based observational study. Diabetologia. 2000;43:558-560. (Pubitemid 30322072)